ClinicalTrials.Veeva

Menu

Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping

D

Damascus University

Status

Completed

Conditions

Patients With Deep Carious Lesions

Treatments

Drug: MTA
Drug: Biodentine

Study type

Interventional

Funder types

Other

Identifiers

NCT02803528
UDDS-OperDent-01-2016

Details and patient eligibility

About

Comparative study between Biodentine and MTA in direct pulp capping of deeply carious teeth.

Enrollment

30 patients

Sex

All

Ages

15 to 30 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. asymptomatic vital molars (upper or lower)
  2. with complete formation of roots
  3. Aged 15 to 30 years.
  4. Accidental point pulp exposure during the process of removing dental caries.

Exclusion criteria

  1. If the molar not vital.
  2. If the molar is symptomatic.
  3. Immature molar.
  4. Patient not in age between (15-30 years).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 2 patient groups

Biodentine
Experimental group
Description:
The exposed area of the pulp is going to be covered with Biodentine.
Treatment:
Drug: Biodentine
MTA
Active Comparator group
Description:
The exposed area of the pulp is going to be covered with MTA
Treatment:
Drug: MTA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems